Statute Details
- Title: Pharmacy Board Rules
- Act Code: PRA2007-R1
- Legislative Type: Subsidiary legislation (SL)
- Authorising Act: Pharmacists Registration Act (Chapter 230, Section 21)
- Current Status: Current version as at 27 Mar 2026
- Revised Edition / Version Reference: Revised Edition 1990 (25th March 1992)
- Commencement Date: Not stated in the provided extract
- Key Provisions (from extract): Sections 1–6 (Citation, Secretary, Address, Meetings, Minutes, Absence from meetings)
What Is This Legislation About?
The Pharmacy Board Rules are procedural rules made under the Pharmacists Registration Act. In plain terms, they set out how the Pharmacy Board (the “Board”) should run its internal governance—how it convenes meetings, how members are notified, how disciplinary-related matters are handled at meetings, and how the Board’s decisions are recorded.
Although the Rules are not a substantive “disciplinary code” by themselves, they are legally important because they govern the process by which the Board conducts its business. Procedural requirements—such as notice periods, the preparation and circulation of documents, and the authentication of minutes—can affect the validity of Board deliberations and the defensibility of Board actions in later proceedings.
Practitioners should view these Rules as a framework for administrative fairness and record-keeping. They ensure that Board members receive adequate notice, that relevant materials are available before deliberations (particularly where complaints and disciplinary matters are concerned), and that the Board maintains an auditable decision trail through properly authenticated minutes.
What Are the Key Provisions?
Section 1 (Citation) provides the short title: the Rules may be cited as the Pharmacy Board Rules. While seemingly minor, citation provisions matter for legal drafting, referencing, and ensuring the correct instrument is relied upon.
Section 2 (Secretary) authorises the Board to elect one of its members to be its secretary. This is a governance mechanism: the secretary is the operational hub for meeting administration. In practice, the secretary’s role becomes central under Section 4 (Meetings of Board), where the secretary must send notice of meetings and ensure that notice requirements are met.
Section 3 (Address) states that the address of the Board shall be the address of the Chief Pharmacist of the Ministry of Health. This provision is significant for service and communications. For example, where the Board’s address is relevant to correspondence, filings, or administrative communications, Section 3 fixes the Board’s official contact point by reference to a specific office-holder and ministry.
Section 4 (Meetings of Board) contains the core procedural requirements for how the Board meets:
- Notice by letter: Under Section 4(1), notice of a meeting must be sent by the secretary by letter addressed to each member. This indicates a formal method of communication and suggests that internal meeting governance is not intended to be informal or ad hoc.
- Seven-day notice for matters to be discussed: Section 4(2) requires that no matter shall be discussed unless seven days’ notice of that matter has been given to members. This is a key fairness safeguard. It ensures members have time to consider the issue, review materials, and prepare questions.
- Disciplinary proceedings require pre-supplied complaints and documents: Section 4(3) provides that no disciplinary proceedings against a pharmacist shall be considered unless copies of all complaints and relevant documents have been supplied to members at least seven days prior to the meeting. This is particularly important for due process. It prevents “surprise” disciplinary deliberations and ensures that Board members base their consideration on complete and relevant information.
Section 5 (Minutes) is the record-keeping and authentication provision. It requires that the Board’s proceedings be documented in minutes and sets out detailed requirements for what the minutes must contain and how they must be authenticated:
- Authentication by chairman’s signature: Section 5(1) requires minutes to be authenticated after confirmation at a meeting by the signature of the chairman at that meeting. This creates an official record and reduces the risk of disputes about what was decided.
- Comprehensive capture of motions and amendments: Section 5(2) requires minutes to contain every motion and amendment proposed and adopted or rejected, including the names of every proposer and seconder. This level of detail supports transparency and accountability.
- Omission of member comments: Section 5(3) allows comments or observations of a member on a motion to be omitted. This balances the need for a clear decision record with practical concerns about minute length and relevance.
- Amendment of minutes: Section 5(4) permits any Board member to propose amendments to the minutes in such manner as he thinks fit. This provides a mechanism to correct or refine the record.
- Formal statement of purpose when amending rules: Section 5(5) requires that when the Board proposes to amend any rule made under the Act, a formal statement on the purpose of the amendment must be recorded in the minutes. This is a governance safeguard ensuring that rule changes are justified and documented.
- Draft circulation after adjournment: Section 5(6) requires that after adjournment of a meeting for a day, a draft of the minutes be sent to every member. This supports timely review and reduces the likelihood of later disagreement about the record.
Section 6 (Absence from meetings) addresses member accountability. If a member is absent without leave from three consecutive meetings, he may be asked to resign. This provision is important for maintaining Board effectiveness and quorum-related reliability. It also signals that the Board expects consistent participation and that non-attendance can have consequences.
How Is This Legislation Structured?
The Pharmacy Board Rules are structured as a short instrument with six sections. The sequence is functional: it begins with formalities (citation), establishes internal roles (secretary), fixes administrative details (address), then sets out meeting procedures (notice and disciplinary document requirements), followed by record-keeping rules (minutes), and finally addresses member conduct and attendance (absence from meetings).
In practical terms, the Rules operate as a procedural “operating manual” for the Board. Sections 4 and 5 are the most operational and legally sensitive: they govern how meetings are convened and how decisions are recorded. Section 6 adds an enforcement mechanism for participation.
Who Does This Legislation Apply To?
The Rules apply to the Pharmacy Board and its members. They govern internal Board processes—how members are notified, how meetings are conducted, and how minutes are authenticated and amended.
While the Rules are directed at the Board’s internal governance, they have downstream effects for pharmacists who may be subject to disciplinary proceedings. Section 4(3) specifically protects pharmacists by ensuring that disciplinary proceedings are not considered unless complaints and relevant documents are supplied to Board members at least seven days before the meeting. This indirectly supports procedural fairness for pharmacists by ensuring the Board’s deliberations are informed and properly prepared.
Why Is This Legislation Important?
For practitioners, the Pharmacy Board Rules matter because they can influence the legality and defensibility of Board decisions. In administrative and professional disciplinary contexts, procedural compliance is often central. If the Board fails to meet the Rules’ notice requirements or does not supply complaints and relevant documents in time, the pharmacist affected may have grounds to challenge the process—depending on the broader statutory framework and the nature of the non-compliance.
Section 4’s seven-day notice requirements are particularly significant. They ensure that Board members receive adequate time to consider matters and that disciplinary proceedings are not conducted on incomplete or last-minute information. This supports fairness and reduces the risk of decisions being made without full consideration of the evidence.
Section 5’s minutes requirements are equally important. Authenticated minutes provide an evidential record of motions, amendments, and decision outcomes. In disputes—whether in judicial review, appeals, or collateral proceedings—authenticated minutes can be critical for establishing what the Board considered and what it decided. The detailed requirements for recording motions and proposer/seconder names also enhance accountability and traceability.
Finally, Section 6’s attendance rule helps maintain the Board’s functioning. While it is framed as a potential resignation request, it underscores that the Board expects active participation and that persistent absence without leave is not acceptable.
Related Legislation
- Pharmacists Registration Act (Chapter 230), particularly Section 21 (authorising the making of the Pharmacy Board Rules)
Source Documents
This article provides an overview of the Pharmacy Board Rules for legal research and educational purposes. It does not constitute legal advice. Readers should consult the official text for authoritative provisions.